These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2563295

  • 1. Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum.
    Bohmaker K, Puza T, Goldstein M, Meller E.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):97-103. PubMed ID: 2563295
    [Abstract] [Full Text] [Related]

  • 2. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL.
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [Abstract] [Full Text] [Related]

  • 3. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices.
    Wolf ME, Galloway MP, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):699-707. PubMed ID: 2869140
    [Abstract] [Full Text] [Related]

  • 4. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons.
    Ackerman JM, Johansen PA, Clark D, White FJ.
    J Pharmacol Exp Ther; 1993 May; 265(2):963-70. PubMed ID: 8098768
    [Abstract] [Full Text] [Related]

  • 6. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
    Meller E, Puza T, Miller JC, Friedhoff AJ, Schweitzer JW.
    J Pharmacol Exp Ther; 1991 May; 257(2):668-75. PubMed ID: 1674531
    [Abstract] [Full Text] [Related]

  • 7. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
    Meller E, Bohmaker K, Namba Y, Friedhoff AJ, Goldstein M.
    Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
    [Abstract] [Full Text] [Related]

  • 8. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
    Strait KA, Kuczenski R.
    Mol Pharmacol; 1986 Jun; 29(6):561-9. PubMed ID: 2872588
    [Abstract] [Full Text] [Related]

  • 9. [Regulation of (-)-sulpiride-induced increase in evoked dopamine release from striatal slices in rat].
    Yamada S, Yokoo H, Nishi S.
    Yakubutsu Seishin Kodo; 1992 Aug; 12(4):193-7. PubMed ID: 1414037
    [Abstract] [Full Text] [Related]

  • 10. Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
    Johnson EA, Tsai CE, Shahan YH, Azzaro AJ.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):133-41. PubMed ID: 8101215
    [Abstract] [Full Text] [Related]

  • 11. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF, Waszczak BL.
    Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304
    [Abstract] [Full Text] [Related]

  • 12. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP, Wolf ME, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
    [Abstract] [Full Text] [Related]

  • 13. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M, White FJ.
    Synapse; 1989 Mar; 4(4):267-80. PubMed ID: 2603146
    [Abstract] [Full Text] [Related]

  • 14. Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum.
    Enz A, Goldstein M, Meller E.
    Mol Pharmacol; 1990 Apr; 37(4):560-5. PubMed ID: 1970116
    [Abstract] [Full Text] [Related]

  • 15. Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals?
    el Mestikawy S, Hamon M.
    J Neurochem; 1986 Nov; 47(5):1425-33. PubMed ID: 2876053
    [Abstract] [Full Text] [Related]

  • 16. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E, Tonello C, Imhof R, Scherschlicht R, da Prada M, Carruba MO.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [Abstract] [Full Text] [Related]

  • 17. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
    Rugsley TA, Davis MD, Akunne HC, Cooke LW, Whetzel SZ, MacKenzie RG, Shih YH, van Leeuwen DH, DeMattos SB, Georgic LM.
    J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753
    [Abstract] [Full Text] [Related]

  • 18. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S, Johansson B, Fredholm BB.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
    [Abstract] [Full Text] [Related]

  • 19. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S, Glowinski J, Hamon M.
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [Abstract] [Full Text] [Related]

  • 20. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H, Lovenberg T, Cubeddu LX.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.